Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	317.27	54.9	32.67	200.7	93.09	40.33
Short-Term Investments	545.4	503.66	301.75	133.01	77.79	78.07
Cash & Short-Term Investments	862.67	558.56	334.43	333.71	170.88	118.39
Cash Growth	55.53%	67.02%	0.22%	95.29%	44.33%	-27.75%
Other Receivables	6.94	9.26	2.9	1.48	1.83	1.15
Receivables	6.94	9.26	2.9	1.48	1.83	1.15
Prepaid Expenses	6.1	3.43	3.51	7.2	1.72	1.32
Other Current Assets	1.88	2.91	4.36	2.34	3.06	2.48
Total Current Assets	877.59	574.15	345.18	344.72	177.49	123.34
Property, Plant & Equipment	55.98	57.43	4.99	4.72	5.41	6.46
Long-Term Investments	2	2.47	-	1.01	-	-
Other Long-Term Assets	1.81	1.3	2.01	0.57	0.54	0.58
Total Assets	937.37	635.35	352.18	351.02	183.45	130.38
Accounts Payable	4.94	6.55	6.88	3.42	3.49	2.7
Accrued Expenses	39.28	27.35	17.19	11.63	6.17	4.92
Current Portion of Leases	7.41	4.17	1.05	0.94	0.84	0.72
Current Unearned Revenue	1.69	2.06	2.24	-	-	-
Other Current Liabilities	0.24	3.82	0.36	-	-	-
Total Current Liabilities	53.56	43.94	27.72	16	10.49	8.34
Long-Term Leases	45.13	47.56	2.02	3.07	4.01	4.85
Long-Term Unearned Revenue	5.2	4.75	6.1	-	-	-
Other Long-Term Liabilities	0.51	-	-	0	0.02	0.05
Total Liabilities	104.39	96.25	35.85	19.07	14.53	13.24
Common Stock	1,702	1,192	759.43	607.58	336.51	210.79
Retained Earnings	-871.52	-653.7	-439.17	-275.26	-167.61	-93.8
Comprehensive Income & Other	2.04	0.98	-3.93	-0.38	0.03	0.15
Total Common Equity	832.98	539.11	316.33	331.94	168.92	117.14
Shareholders' Equity	832.98	539.11	316.33	331.94	168.92	117.14
Total Liabilities & Equity	937.37	635.35	352.18	351.02	183.45	130.38
Total Debt	52.54	51.73	3.08	4.01	4.85	5.57
Net Cash (Debt)	810.13	506.83	331.35	329.69	166.03	112.82
Net Cash Growth	61.23%	52.96%	0.50%	98.57%	47.17%	-31.16%
Net Cash Per Share	10.85	8.73	6.37	8.58	5.45	4.67
Filing Date Shares Outstanding	92.74	69.6	53.91	47.78	33.03	24.57
Total Common Shares Outstanding	80.84	68.18	53.88	47.6	33	24.26
Working Capital	824.03	530.21	317.46	328.73	167	115
Book Value Per Share	10.30	7.91	5.87	6.97	5.12	4.83
Tangible Book Value	832.98	539.11	316.33	331.94	168.92	117.14
Tangible Book Value Per Share	10.30	7.91	5.87	6.97	5.12	4.83
Machinery	7.64	6.11	4.07	2.79	2.25	2.08
Leasehold Improvements	11.05	9.84	3.52	3.52	3.49	3.49

Source: S&P Capital IQ. Standard template. Financial Sources.